Ethynerone

From WikiMD's WELLNESSPEDIA

Ethynerone is a synthetic progestogen that was developed in the mid-20th century. It is a derivative of testosterone and is structurally related to other synthetic progestogens such as norethisterone and ethisterone. Ethynerone was primarily investigated for its potential use in hormonal contraception and hormone replacement therapy.

Chemical Structure[edit]

Ethynerone belongs to the class of 19-nortestosterone derivatives. Its chemical structure is characterized by the presence of an ethynyl group at the 17α position of the steroid nucleus, which is a common feature among many synthetic progestogens. This modification enhances the oral bioavailability and progestogenic activity of the compound.

Mechanism of Action[edit]

As a progestogen, ethynerone exerts its effects by binding to the progesterone receptors in target tissues. This binding mimics the action of natural progesterone, leading to changes in the endometrium that are necessary for the maintenance of pregnancy and the regulation of the menstrual cycle. Ethynerone also has some degree of androgenic activity due to its structural similarity to testosterone.

Clinical Uses[edit]

Ethynerone was investigated for several clinical applications, including:

However, ethynerone was not widely adopted in clinical practice, and its use has been largely supplanted by other synthetic progestogens with more favorable profiles.

Side Effects[edit]

The side effects of ethynerone are similar to those of other synthetic progestogens and may include:

History and Development[edit]

Ethynerone was developed during the 1950s and 1960s, a period of significant advancements in the field of synthetic progestogens. The development of ethynerone and related compounds was driven by the need for effective and reliable hormonal contraceptives and hormone replacement therapies.

See Also[edit]

References[edit]


External Links[edit]


Ethynerone[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.